This is the first study to show a clear benefit of GLP-1 receptor agonists on kidney failure or end-stage kidney disease, suggesting they have a key role in kidney-protective and heart-protective treatment for patients with common medical conditions like type 2 diabetes, overweight or obesity with cardiovascular disease, or CKD [chronic kidney disease], said lead author Sunil Badve, professorial fellow at The George Institute for Global Health and UNSW Sydney
References: Butterworth (2018)
However, in some cases, more severe bruising or swelling may occur, which may require medical attention
Up-and-coming medications such as Retatrutide and Cagrilintide are on the horizon, indicating a potential shift in treating obesity and managing diabetes
These may vary based on the types of ingredients used and your provider
Storage condition: Store in a cool, dry and dark place